February 2026 - Page 2

Multiple myeloma is a complex blood cancer that affects plasma cells—an important type of white blood cell responsible for producing antibodies. Advances in stem cell therapy have significantly improved outcomes for many

Multiple myeloma is a complex blood cancer that affects plasma cells in the bone marrow, disrupting normal blood cell production and weakening the immune system. Over the past few decades, stem cell

Multiple myeloma is a complex blood cancer that affects plasma cells in the bone marrow. Because its symptoms often overlap with other conditions, reaching an accurate and timely diagnosis is essential. When

Multiple myeloma is a complex blood cancer that affects plasma cells in the bone marrow. Over the past few decades, treatment outcomes for multiple myeloma have improved significantly, largely due to advances

Recovery after a stem cell transplant for multiple myeloma is a gradual and carefully monitored process. While the procedure itself is a major milestone in treatment, long-term success depends heavily on structured

Myelodysplastic Syndrome (MDS) is a group of complex blood disorders that originate in the bone marrow, where blood cells are produced. When stem cells—the foundational cells responsible for generating healthy blood components—fail

Myelodysplastic Syndrome (MDS) is a group of complex bone marrow disorders that affect the body’s ability to produce healthy blood cells. Over time, MDS can lead to serious complications such as anemia,

Myelodysplastic Syndrome (MDS) is a complex group of bone marrow disorders in which the body fails to produce healthy, functional blood cells. Accurate diagnosis and thorough evaluation are critical for determining disease